Prous Institute signs Investment Agreement with Chemotargets By Montserrat CasesNews, ScienceBarcelona, May 2017 – Prous Institute for Biomedical Research announced today that it has made a strategic investment in Chemotargets SL. Founded by Dr. Jordi Mestres as a spin-off of...Read More 06/06/2017 Love0